Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins

Details for Australian Patent Application No. 2006257664 (hide)

Owner Protox Therapeutics Incorporated

Inventors Buckley, James Thomas

Agent Spruson & Ferguson

Pub. Number AU-A-2006257664

PCT Pub. Number WO2006/133553

Priority 60/690,269 14.06.05 US

Filing date 14 June 2006

Wipo publication date 21 December 2006

International Classifications

C07K 14/195 (2006.01) Peptides having more than 20 amino acids - from bacteria

A61K 35/74 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

Event Publications

24 January 2008 PCT application entered the National Phase

  PCT publication WO2006/133553 Priority application(s): WO2006/133553

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006257667-Retractable screen door housing handle balancing system

2006257660-Diet supplement comprising Hoodia Gordonii for weight loss and mental well-being